Results 111 to 120 of about 50,825 (299)

A Short Review on Application and Comparison of Novel Active Packaging and MPA in Meat Packaging and Meat Products [PDF]

open access: yes, 2015
Food process technology has been improved different packaging methods in improving shelf life of perishable foods such as meat and meat products. Regarding that improving of contamination have caused to develop and enhancement of active packaging in ...
Kaviani, Mehdi, Tomovska, Julijana
core  

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

Halochromic properties of carotenoid-based films for smart food packaging

open access: yes
Carotenoids are fat-soluble natural pigments with potent antioxidant and antibacterial properties, and their colors are sensitive to environmental pH changes (halochromic properties).
Mustafa, Ahmad   +5 more
core   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

Patent Analysis and Trends Related to 2D Nanomaterials for Active Food Packaging

open access: yesEngineering Proceedings
Active food packaging technology encompasses systems that incorporate active substances into the polymeric matrix. The embedded components exhibit antimicrobial, antifungal, and antioxidant properties and are able to absorb or reduce oxygen, carbon ...
Massimo Barbieri
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Active biopolymer films from oil-in-water pickering emulsions for food preservation: a mini review

open access: yesFrontiers in Soft Matter
In response to societal demands, the food industry constantly seeks innovations for its products. Active food packaging, developed from biopolymers incorporated with Pickering emulsions, is certainly one of these innovations.
Rodrigo F. Gouvêa, Cristina T. Andrade
doaj   +1 more source

Study of natural compounds of Rosmarinus Officinalis as additives in food active packaging.

open access: yes, 2015
The use of natural extracts categorized as flavorings by the European Union (EU) and generally recognized as safe (GRAS) by the US Food and Drug Administration (FDA), represents an interesting approach in the active packaging technology.
C. Cecchini   +6 more
core  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy